These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11120009)

  • 1. Prevalence of abnormal liver function and hepatitis B antigenemia in hepatitis B antibody positive kidney transplant patients.
    Luvira U; Kanjanakul I; Kuvanont S
    Transplant Proc; 2000 Nov; 32(7):1937-8. PubMed ID: 11120009
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term impact of hepatitis B and C virus infection in kidney transplant recipient's survival.
    Correa JR; Rocha F; Peres AA; Gonçalves LF; Manfro RC
    Transplant Proc; 2003 May; 35(3):1076-7. PubMed ID: 12947864
    [No Abstract]   [Full Text] [Related]  

  • 3. Eleven-year experience of kidney transplantation in patients with hepatitis B and C infection.
    Sumethkul V; Jirakranont B; Jirasiritham S; Pairoj W
    Transplant Proc; 2000 Nov; 32(7):1944-5. PubMed ID: 11120012
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of donor hepatitis B antigenemia on renal allograft in hepatitis B recipients.
    Chen JB; Hsieh H; Hsu KT; Chen CH
    Transplant Proc; 1996 Jun; 28(3):1490-2. PubMed ID: 8658755
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver function tests in hepatitis C virus infected kidney transplant recipients.
    Manfro RC; Karohl C; Goncalves LF; Senger MB; Thomé FS; Prompt CA
    Transplant Proc; 1995 Apr; 27(2):1821-2. PubMed ID: 7725519
    [No Abstract]   [Full Text] [Related]  

  • 6. HBV and HCV infection before and after kidney transplantation.
    Gorgi Y; Ayed K; Ben Abdallah T; Kammoun A; Ben Maïz H
    Transplant Proc; 2001 Aug; 33(5):2856-7. PubMed ID: 11498188
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of diabetes mellitus in renal transplant patients with hepatitis B or C virus infection.
    Hirakauva EY; Ferraz ML; Perez RM; Ferreira AS; Silva AE; Hauache O; Pestana JO
    Transplant Proc; 2002 Dec; 34(8):3220-2. PubMed ID: 12493426
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and clinical significance of hepatitis C in kidney transplantation.
    Kubo M; Fujimoto N; Ihara H; Hanafusa T; Nojima M; Koike H; Ichikawa Y; Fukunishi T; Arima M; Nagano S
    Transplant Proc; 1994 Aug; 26(4):2121-2. PubMed ID: 7520624
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C in kidney transplant patients.
    Oka T; Yasumura T
    Transplant Proc; 1996 Jun; 28(3):1163-7. PubMed ID: 8658612
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients.
    Stempel C; Lake J; Ferrell L; Tomlanovich S; Amend W; Salvatierra O; Vincenti F
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1251-2. PubMed ID: 1989202
    [No Abstract]   [Full Text] [Related]  

  • 11. Occult hepatitis B in renal transplant patients.
    Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
    Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of isolated infection by hepatitis C (HCV) or by hepatitis B (HBV) viruses and of coinfection by HCV-HBV in 1098 renal transplant patients.
    Pouteil-Noble C; Maiza H; Donia A; Mercier S; Chossegros P; Gérard F; Mion F; Chevallier P; Touraine JL
    Transplant Proc; 1997; 29(1-2):791-2. PubMed ID: 9123527
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of hepatitis B or C infection on the practice of kidney transplantation in the United States.
    Schweitzer EJ; Bartlett ST; Keay S; Hadley GA; Cregar J; Stockdreher DD
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1456-7. PubMed ID: 8442157
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronic liver disease on clinical outcome in renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Rancewicz Z; Kozłowska-Boszko B; Lewandowski Z; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1997; 29(1-2):787-90. PubMed ID: 9123526
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B and C in renal transplantation in Taiwan.
    Hu RH; Lee PH; Chung YC; Huang MT; Lee CS
    Transplant Proc; 1994 Aug; 26(4):2059-61. PubMed ID: 7520621
    [No Abstract]   [Full Text] [Related]  

  • 16. The significance and implications of hepatitis B infection in renal transplant recipients.
    Dhar JM; al-Khader AA; al-Sulaiman MH; al-Hasani MK
    Transplant Proc; 1991 Apr; 23(2):1785-6. PubMed ID: 2053154
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between the accumulation of hepatitis B virus core gene deletion mutants and progression of liver disease in long-term renal transplant patients.
    Reinke P; Baginski S; Günther S; Krüger DH; Will H; Meisel H
    Transplant Proc; 1997; 29(1-2):815-6. PubMed ID: 9123538
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine.
    Tsai MK; Lai MY; Hu RH; Lee CJ; Lee PH
    Transplant Proc; 2000 Nov; 32(7):1935-6. PubMed ID: 11120008
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus infection among Greek renal transplant patients.
    Vafiadis I; Boletis J; Papastathi H; Delladetsima J; Stathakis C; Hatzakis A; Kostakis A; Vosnides G
    Gut; 1993; 34(2 Suppl):S57-8. PubMed ID: 8314493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.